These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 18115401)

  • 1. The pathology of the thymus in myasthenia gravis; a study of 35 cases.
    CASTLEMAN B; NORRIS EH
    Medicine (Baltimore); 1949 Feb; 28(1):27-58. PubMed ID: 18115401
    [No Abstract]   [Full Text] [Related]  

  • 2. Are the minimally invasive techniques the new gold standard in thymus surgery for myasthenia gravis? Experience of a reference single-site in VATS thymectomy.
    Trujillo Reyes JC; Martinez Tellez E; Belda Sanchis J; Planas Canovas G; Libreros Niño A; Guarino M; Hernández Ferrandez J; Moral Duarte A
    Front Neurol; 2024; 15():1309173. PubMed ID: 38361645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The spectrum of ectopic thymomas.
    Weissferdt A; Moran CA
    Virchows Arch; 2016 Sep; 469(3):245-54. PubMed ID: 27255665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proceedings of the 2014 National Toxicology Program Satellite Symposium.
    Elmore SA; Cora MC; Gruebbel MM; Hayes SA; Hoane JS; Koizumi H; Peters R; Rosol TJ; Singh BP; Szabo KA
    Toxicol Pathol; 2015 Jan; 43(1):10-40. PubMed ID: 25385331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteasome inhibition with bortezomib depletes plasma cells and specific autoantibody production in primary thymic cell cultures from early-onset myasthenia gravis patients.
    Gomez AM; Willcox N; Vrolix K; Hummel J; Nogales-Gadea G; Saxena A; Duimel H; Verheyen F; Molenaar PC; Buurman WA; De Baets MH; Martinez-Martinez P; Losen M
    J Immunol; 2014 Aug; 193(3):1055-1063. PubMed ID: 24973445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myasthenia gravis thymus: complement vulnerability of epithelial and myoid cells, complement attack on them, and correlations with autoantibody status.
    Leite MI; Jones M; Ströbel P; Marx A; Gold R; Niks E; Verschuuren JJ; Berrih-Aknin S; Scaravilli F; Canelhas A; Morgan BP; Vincent A; Willcox N
    Am J Pathol; 2007 Sep; 171(3):893-905. PubMed ID: 17675582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 'Split tolerance' induction by intrathymic injection of acetylcholine receptor in a rat model of autoimmune myasthenia gravis; implications for the design of specific immunotherapies.
    Ohtsuru I; Matsuo H; Fukudome T; Suenaga A; Tsujihata M; Nagataki S
    Clin Exp Immunol; 1995 Dec; 102(3):462-7. PubMed ID: 8536358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myasthenia gravis: overlap with 'polyendocrine' autoimmunity.
    Scherbaum WA; Schumm F; Maisch B; Müller C; Fateh-Moghadam A; Flüchter SH; Seif FJ; Bottazzo GF; Berg PA
    Klin Wochenschr; 1983 May; 61(10):509-15. PubMed ID: 6876683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thymectomy in myasthenia gravis. A review.
    Oosterhuis HJ
    Ital J Neurol Sci; 1983 Dec; 4(4):399-407. PubMed ID: 6370908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The immunohistology of the thymus in myasthenia gravis.
    Kornstein MJ; Brooks JJ; Anderson AO; Levinson AI; Lisak RP; Zweiman B
    Am J Pathol; 1984 Nov; 117(2):184-94. PubMed ID: 6208785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Lymph follicles in the thymus in cases of ulcerative colitis].
    Cesnik H; Schmid KO
    Langenbecks Arch Chir; 1971; 328(2):128-38. PubMed ID: 5554677
    [No Abstract]   [Full Text] [Related]  

  • 12. [Experimental thymitis, myocarditis and polymyositis. A contribution to the pathogenesis of myasthenia gravis Erb].
    Griss P; Fahr K
    Arch Kreislaufforsch; 1970; 63(3):257-65. PubMed ID: 4928860
    [No Abstract]   [Full Text] [Related]  

  • 13. Thyrotoxic muscle disease.
    Ramsay I
    Postgrad Med J; 1968 May; 44(511):385-97. PubMed ID: 4871773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The pathogenesis of myasthenia gravis as an immunological problem].
    Kalden JR
    Klin Wochenschr; 1970 Jan; 48(1):4-13. PubMed ID: 4330544
    [No Abstract]   [Full Text] [Related]  

  • 15. [Thymectomy in the management of myasthenia].
    Balzereit F; Bay V; Otto H; Rittmeyer P; Sobirey C
    Z Neurol; 1972; 201(2):136-59. PubMed ID: 4112645
    [No Abstract]   [Full Text] [Related]  

  • 16. Thymic hyperplasia. I. True thymic hyperplasia. Review of the literature.
    Hofmann WJ; Möller P; Otto HF
    Klin Wochenschr; 1987 Jan; 65(2):49-52. PubMed ID: 3560787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thymopoietin to thymopentin: experimental studies.
    Goldstein G; Audhya TK
    Surv Immunol Res; 1985; 4 Suppl 1():1-10. PubMed ID: 2994196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Desensitization of the nicotinic acetylcholine receptor: molecular mechanisms and effect of modulators.
    Ochoa EL; Chattopadhyay A; McNamee MG
    Cell Mol Neurobiol; 1989 Jun; 9(2):141-78. PubMed ID: 2663167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thymic hyperplasia. II. Lymphofollicular hyperplasia of the thymus. An immunohistologic study.
    Hofmann WJ; Möller P; Otto HF
    Klin Wochenschr; 1987 Jan; 65(2):53-60. PubMed ID: 2435953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiologic evaluation of the thymus in juvenile myasthenia gravis.
    Thurmond AS; Brasch RC
    Pediatr Radiol; 1978 Sep; 7(3):136-40. PubMed ID: 714525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.